LAINGAX Trademark Information

Trademark by Tanvex BioPharma, Inc.

pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: LAINGAX
Status/Status Date:
NEW APPLICATION FILED
5/21/2021
Serial Number: 90717653
Filing Date: 5/18/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
Tanvex BioPharma, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
NEW APPLICATION FILED
5/21/2021
Correspondent Search:
GABRIELLE S. ROTH is a correspondent of LAINGAX trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on